T1	Outcomes 33 45	irritability
T2	Outcomes 153 183	short-term efficacy and safety
T3	Outcomes 220 232	irritability
T4	Outcomes 726 837	Aberrant Behavior Checklist irritability subscale and the Clinical Global Impression-Improvement score (CGI-I).
T5	Outcomes 838 861	Safety and tolerability
T6	Outcomes 1009 1064	Aberrant Behavior Checklist irritability subscale score
T7	Outcomes 1261 1272	CGI-I score
T8	Outcomes 1333 1350	residual symptoms
T9	Outcomes 1388 1409	Discontinuation rates
T10	Outcomes 1496 1535	Extrapyramidal symptom-related AE rates
T11	Outcomes 1621 1632	weight gain
